Massachusetts v. Purdue

Raymond Sackler Family Launches Comprehensive Website To Correct False Narrative About Role In Opioid Crisis

Retrieved on: 
Wednesday, May 19, 2021

b"The Raymond Sackler family today released documents and information (available at the website www.judgeforyourselves.info ) that address the many false allegations blaming family members, Purdue Pharma and OxyContin for creating the tragic opioid crisis in the United States.

Key Points: 
  • b"The Raymond Sackler family today released documents and information (available at the website www.judgeforyourselves.info ) that address the many false allegations blaming family members, Purdue Pharma and OxyContin for creating the tragic opioid crisis in the United States.
  • The website, based entirely on publicly-available documents and data, includes detailed information about the origins of the opioid crisis, which long predated the launch of OxyContin in 1996, and on the FDA\xe2\x80\x99s continuing approval (including to this day) of OxyContin for patients suffering from chronic pain.\nThe interactive website, which allows interested users to search content, includes a series of video presentations based on historical documents and information made public, with the Sacklers\xe2\x80\x99 consent, as part of the Purdue Pharma bankruptcy proceedings.
  • These documents clearly establish that Sackler family members who served on Purdue's board conducted themselves ethically and lawfully at all times.\nThe presentations and information available on the website reveal how the false narratives about the Sackler family and its alleged role in the opioid crisis were orchestrated by plaintiffs\xe2\x80\x99 lawyers, who clearly articulated\xe2\x80\x94and stand to benefit from\xe2\x80\x94their plans to vilify Purdue and the Sackler family.
  • They remain committed to resolutions that will provide substantial resources for addressing the opioid crisis.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210519005818/en/\n"

Members of the Sackler Family Who Served on Purdue's Board Issue Statement about Department of Justice Announcement

Retrieved on: 
Wednesday, October 21, 2020

Members of the Sackler family who served on Purdue's board issued the following statement today about the Department of Justice announcement:

Key Points: 
  • Members of the Sackler family who served on Purdue's board issued the following statement today about the Department of Justice announcement:
    "Members of the Sackler family who served on Purdue's board of directors acted ethically and lawfully, and the upcoming release of company documents will prove that fact in detail.
  • This history of Purdue will also demonstrate that all financial distributions were proper.
  • "As members of the board, we adopted rigorous policies requiring Purdue to be in full compliance with the law.
  • "Regarding the plea agreement between the government and Purdue, no member of the Sackler family was involved in that conduct or served in a management role at Purdue during that time period."

Purdue Pharma Reaches Agreement With U.S. Department of Justice

Retrieved on: 
Wednesday, October 21, 2020

Purdue Pharma L.P. (Purdue) today announced that it has entered into an agreement with the United States Department of Justice (DOJ) to resolve multi-year civil and criminal investigations into the companys past marketing practices related to its opioid medicines.

Key Points: 
  • Purdue Pharma L.P. (Purdue) today announced that it has entered into an agreement with the United States Department of Justice (DOJ) to resolve multi-year civil and criminal investigations into the companys past marketing practices related to its opioid medicines.
  • With the agreement, Purdue accepts responsibility for specified misconduct that took place before June 2017 and resolves allegations regarding conduct between 2007 and February 2018 by pleading guilty and agreeing to pay fines and forfeiture.
  • Importantly, the overwhelming majority of these settlement funds will be directed to state, local and tribal governments to address the opioid crisis.
  • Purdue deeply regrets and accepts responsibility for the misconduct detailed by the Department of Justice in the agreed statement of facts, said Steve Miller, who joined Purdues Board as Chairman in July 2018.

Purdue Pharma L.P. and the National Center for Wellness & Recovery at Oklahoma State University Announce Collaboration Around Research to Address the Opioid Addiction Crisis

Retrieved on: 
Thursday, August 15, 2019

Purdue Pharma L.P. (Purdue) and the National Center for Wellness & Recovery (the Center) at Oklahoma State University today announced an innovative collaboration focused on accelerating solutions to the opioid addiction crisis.

Key Points: 
  • Purdue Pharma L.P. (Purdue) and the National Center for Wellness & Recovery (the Center) at Oklahoma State University today announced an innovative collaboration focused on accelerating solutions to the opioid addiction crisis.
  • This collaboration presents new and exciting opportunities at the scientific level that would not be available without Purdues years of extensive research.
  • The opioid addiction crisis has taken a tremendous toll on individuals, families, and communities across the nation, said Craig Landau, MD, president and CEO, Purdue Pharma.
  • Dr. Landau added, Through years of research and innovation, Purdue has accumulated knowledge around opioid analgesics and other investigational entities.

Motions to Dismiss Submitted by Sackler Family Members Named in Massachusetts Complaint

Retrieved on: 
Tuesday, April 2, 2019

Mortimer and Raymond Sackler families, have submitted Motions to Dismiss the misleading complaint filed against them by the Massachusetts Attorney General.

Key Points: 
  • Mortimer and Raymond Sackler families, have submitted Motions to Dismiss the misleading complaint filed against them by the Massachusetts Attorney General.
  • The Motions to Dismiss detail the distortions and mischaracterizations that riddle the amended complaint which overlooks the proper role of a Board of Directors in corporate governance.
  • The family members have great sympathy for those suffering from addiction and are fully committed to contributing to solutions to the nation's complex crisis of opioid abuse.
  • The complaint devotes three paragraphs to the inaccurate suggestion that Richard Sackler went intothe field to promote opioids to doctors alongside a sales rep in 2011.

Statement of Sackler Family Defendants in Response to the NY Attorney General Amended Complaint

Retrieved on: 
Thursday, March 28, 2019

The following statement is for attribution to a spokesperson for the Sackler family defendants named in the New York Attorney Generals amended complaint.

Key Points: 
  • The following statement is for attribution to a spokesperson for the Sackler family defendants named in the New York Attorney Generals amended complaint.
  • Expanding this baseless lawsuit to include former directors of Purdue Pharma is a misguided attempt to place blame where it does not belong for a complex public health crisis.
  • We strongly deny these allegations, which are inconsistent with the factual record, and will vigorously defend against them.
  • Solving this complex public health crisis will require collaboration and focus on the real problems our nation needs to address.

Purdue Pharma Announces Landmark Agreement with Oklahoma to Advance the Treatment of Addiction

Retrieved on: 
Tuesday, March 26, 2019

Purdue Pharma L.P. today announced that it has entered into a landmark agreement with the state of Oklahoma that will establish a National Center for Addiction Studies and Treatment at Oklahoma State University (OSU) in Tulsa.

Key Points: 
  • Purdue Pharma L.P. today announced that it has entered into a landmark agreement with the state of Oklahoma that will establish a National Center for Addiction Studies and Treatment at Oklahoma State University (OSU) in Tulsa.
  • Purdue is very pleased to have reached an agreement with Oklahoma that will help those who are battling addiction now and in the future, said Craig Landau, MD, president and CEO, Purdue Pharma.
  • We applaud Attorney General Mike Hunter for his leadership in making such an agreement possible.
  • Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers.

Hearings against Drug manufacturers and distributors motion to dismiss to be heard in Clark County Opioid case

Retrieved on: 
Tuesday, February 26, 2019

The Defendants (Drug manufacturers and Distributors) filed motions to dismiss in the Clark County Opioids case.

Key Points: 
  • The Defendants (Drug manufacturers and Distributors) filed motions to dismiss in the Clark County Opioids case.
  • In December 2017 Clark County, Nevada filed a lawsuit against opioid distributors and manufacturers, as Clark County residents deal with the ongoing opioid epidemic.
  • Local governments including Clark County have been strained to the breaking point by this public health crisis.
  • Links to December 2017 stories:
    The Clark County District Attorney's Office is working in association with the local law firm of Eglet Prince.